STOCK TITAN
  1. Home
  2. Sec-filings
  3. KNSA
  4. [Form 4] Kiniksa Pharmaceuticals International, plc Insider Trading Activity

Kiniksa Pharmaceuticals (KNSA) director converts 403 RSUs to shares

Filing Impact
(Neutral)
Filing Sentiment
(Neutral)
Form Type
4

Rhea-AI Filing Summary

Kiniksa Pharmaceuticals International, plc director Richard S. Levy received an award of 403 Restricted Share Units on August 1, 2026. Each RSU represents a contingent right to receive one Class A Ordinary Share and vested immediately upon grant. The RSUs were then exercised and converted into 403 Class A Ordinary Shares, bringing his direct holdings to 22,359 shares, with no share sales reported.

Positive

  • None.

Negative

  • None.
Insider Levy Richard S
Role Director
Type Security Shares Price Value
Grant/Award Restricted Share Units F1, F2 403 $0.00 $0.00
Exercise Restricted Share Units F1, F2 403 $0.00 $0.00
Exercise Class A Ordinary Share F1 403 -- --
Holdings After Transaction: Restricted Share Units — 0 shares (Direct); Class A Ordinary Share — 22,359 shares (Direct)
Footnotes (2)
  1. F1. Each Restricted Share Unit (RSU) represents a contingent right to receive one Class A Ordinary Share of the Issuer.
  2. F2. The RSUs vested immediately upon grant on August 1, 2026; there was no expiration date for the RSUs.
RSUs granted 403 Restricted Share Units Award to director Richard S. Levy on August 1, 2026
RSUs converted 403 Restricted Share Units RSUs exercised and converted into Class A Ordinary Shares on August 1, 2026
Class A Ordinary Shares acquired 403 shares Shares received upon RSU conversion on August 1, 2026
Shares owned after transaction 22,359 shares Direct Class A Ordinary Share holdings of Richard S. Levy following the reported transactions
Transaction date August 1, 2026 Date of RSU grant, vesting, and share issuance
Restricted Share Unit financial
"Each Restricted Share Unit (RSU) represents a contingent right to receive one Class A Ordinary Share"
A restricted share unit (RSU) is a promise by a company to give an employee a set number of company shares at a future date, typically after meeting time or performance conditions. For investors, RSUs matter because when they convert into actual shares they increase the number of shares outstanding (like unlocking more tickets in a game), which can dilute existing holders, and they align employee incentives with company performance, influencing behavior and long-term value.
contingent right financial
"Each RSU represents a contingent right to receive one Class A Ordinary Share of the Issuer"
derivative security financial
"Transaction code M is described as an exercise or conversion of derivative security"
A derivative security is a financial contract whose value comes from the price or performance of something else, such as a stock, bond, commodity, or market index. For investors it acts like an insurance policy or a wager: it can be used to protect against losses, lock in prices, or amplify gains and losses, so it can change a portfolio’s risk and potential return without owning the underlying asset directly.
Class A Ordinary Share financial
"Each RSU represents a contingent right to receive one Class A Ordinary Share of the Issuer"
A Class A ordinary share is a type of common stock a company issues that carries a specific set of rights—most often particular voting power, dividend terms, or transfer rules—distinct from other share classes. For investors it matters because those rights affect control over company decisions, how income is paid out, and how easy shares are to buy or sell; think of it like a tiered ticket that gives different access and influence at the same event.

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google
Add on Google
Form 4 Insider Transactions: What Each Field Means →

FAQ

What insider transaction did KNSA director Richard S. Levy report?
Richard S. Levy reported receiving 403 Restricted Share Units on August 1, 2026, which vested immediately and were exercised into 403 Class A Ordinary Shares. Following this RSU grant and conversion, his direct ownership increased to 22,359 Class A Ordinary Shares.

How many Restricted Share Units did Richard S. Levy receive from KNSA?
He received an award of 403 Restricted Share Units (RSUs) on August 1, 2026. Each RSU represents a contingent right to one Class A Ordinary Share. These RSUs vested immediately upon grant and were then exercised, resulting in issuance of 403 Class A Ordinary Shares.

How many Kiniksa (KNSA) Class A Ordinary Shares does Richard S. Levy now hold?
After the reported transactions, Richard S. Levy directly holds 22,359 Class A Ordinary Shares. This balance reflects the 403 shares acquired through the immediate vesting and conversion of RSUs on August 1, 2026, with no sales disclosed in the filing.

Were any KNSA shares sold by Richard S. Levy in this Form 4 filing?
No share sales were reported. The Form 4 shows an RSU grant of 403 units that vested immediately and a corresponding conversion into 403 Class A Ordinary Shares. All reported movements are awards and exercises, with no disposition of Class A Ordinary Shares listed.

Did Richard S. Levy’s KNSA RSUs vest immediately or over time?
The 403 RSUs vested immediately upon grant on August 1, 2026. A footnote states that the RSUs vested at grant and had no expiration date, allowing them to be promptly exercised into 403 Class A Ordinary Shares on the same date.

Were Richard S. Levy’s KNSA transactions designated under a Rule 10b5-1 trading plan?
The filing does not designate these transactions as made under a Rule 10b5-1 trading plan. The document-level indicator for an affirmative Rule 10b5-1 plan representation is not marked as true, so the transactions are reported without that plan status.
SEC Form 4
FORM 4UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940
OMB APPROVAL
OMB Number:3235-0287
Estimated average burden
hours per response:0.5
Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).
Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.
1. Name and Address of Reporting Person*
Levy Richard S
(Last)(First)(Middle)
C/O KINIKSA PHARMACEUTICALS INT'L
105 PICCADILLY, SECOND FLOOR
(Street)
LONDONW1J 7NJ
(City)(State)(Zip)
UNITED KINGDOM
(Country)		2. Issuer Name and Ticker or Trading Symbol
Kiniksa Pharmaceuticals International, plc [ KNSA ] 		5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)
XDirector10% Owner
Officer (give title below)Other (specify below)
2a. Foreign Trading Symbol
3. Date of Earliest Transaction (Month/Day/Year)
08/01/2026		6. Individual or Joint/Group Filing (Check Applicable Line)
XForm filed by One Reporting Person
Form filed by More than One Reporting Person
4. If Amendment, Date of Original Filed (Month/Day/Year)

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3) 2. Transaction Date (Month/Day/Year)2A. Deemed Execution Date, if any (Month/Day/Year)3. Transaction Code (Instr. 8) 4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5) 5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4) 6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 7. Nature of Indirect Beneficial Ownership (Instr. 4)
CodeVAmount(A) or (D)Price
Class A Ordinary Share08/01/2026M403A(1)22,359D
Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned
(e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3) 2. Conversion or Exercise Price of Derivative Security 3. Transaction Date (Month/Day/Year)3A. Deemed Execution Date, if any (Month/Day/Year)4. Transaction Code (Instr. 8) 5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5) 6. Date Exercisable and Expiration Date (Month/Day/Year)7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4) 8. Price of Derivative Security (Instr. 5) 9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4) 10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 11. Nature of Indirect Beneficial Ownership (Instr. 4)
CodeV(A)(D)Date ExercisableExpiration DateTitleAmount or Number of Shares
Restricted Share Units(1)08/01/2026A403 (2) (2)Class A Ordinary Shares403$0403D
Restricted Share Units(1)08/01/2026M403 (2) (2)Class A Ordinary Shares403$00D
Explanation of Responses:
1. Each Restricted Share Unit (RSU) represents a contingent right to receive one Class A Ordinary Share of the Issuer.
2. The RSUs vested immediately upon grant on August 1, 2026; there was no expiration date for the RSUs.
/s/ Douglas Barry, Attorney-in-Fact08/04/2026
** Signature of Reporting PersonDate
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
* Form 4: SEC 1474 (03-26)

Source: View Original Filing on SEC EDGAR